针对pyruvate kinase M2用于治疗脏疾病的治疗
Dan-Qian Chen1, Jin Han1,2, Hui Liu1
1College of Life Sciences, Northwest University, Xi'an, Shaanxi, China.
Frontiers in pharmacology
|June 24, 2024
概括
酸激酶M2 (PKM2) 通过调节细胞代谢,影响脏健康. 调节PKM2为糖尿病病和急性损伤等病提供了潜在的治疗策略.
科学领域:
- 生物化学 生物化学
- 细胞生物学 细胞生物学
- 腎臟病學 (nephrology) 是一種醫學專業.
背景情况:
- 酸盐激酶M2 (PKM2) 是一个关键的糖溶性酶,调节细胞代谢和能量.
- 脏是代谢活跃的器官,依靠糖解来获得能量.
- 在病中,PKM2活性发生改变,包括糖尿病病和急性损伤.
研究的目的:
- 审查PKM2在病进展和治疗中的作用.
- 探索PKM2作为脏疾病的潜在治疗标和生物标志物.
主要方法:
- 在病理生理学中对PKM2研究的文献综述.
- 关于PKM2翻译后修改及其影响的证据分析.
- 在病模型中检查PKM2激活剂和抑制剂的治疗潜力.
主要成果:
- PKM2失调与脏疾病的进展有关.
- 翻译后PKM2的修改会影响其活性和核转位,影响细胞过程.
- 在临床前脏疾病模型中,PKM2激活剂和抑制剂显示出治疗前景.
- PKM2在脏中表现出类效应,影响新陈代谢,细胞损伤,纤维细胞激活和免疫细胞两极分化.
结论:
- 在脏疾病中,PKM2发挥着多方面的作用.
- 通过激活剂或抑制剂向PKM2代表了一个有前途的治疗途径.
- 进一步研究PKM2的类作用对于临床转化至关重要.
- PKM2是脏疾病的潜在生物标志物和治疗点.
更多相关视频
15:43Assessment of Mitochondrial Functions and Cell Viability in Renal Cells Overexpressing Protein Kinase C Isozymes
Published on: January 7, 2013
18.2K
07:15Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
392
相关概念视频
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
01:46Electron Transport Chain: Complex I and II
12.9K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
12.9K